Susann Winter

Dresden, SN 01307, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Deep learning differentiates myeloproliferative neoplasms and predicts JAK2 and CALR mutations from bone marrow smears.

Deep learning differentiates myeloproliferative neoplasms and predicts JAK2 and CALR mutations from bone marrow smears.

Journal: Annals of hematology
Published: July 03, 2026

Preclinical efficacy of tasquinimod in myelodysplastic neoplasms: Restoring erythropoiesis and mitigating bone loss.

Preclinical efficacy of tasquinimod in myelodysplastic neoplasms: Restoring erythropoiesis and mitigating bone loss.

Journal: HemaSphere
Published: September 01, 2025

Image-based explainable artificial intelligence accurately identifies myelodysplastic neoplasms beyond conventional signs of dysplasia.

Image-based explainable artificial intelligence accurately identifies myelodysplastic neoplasms beyond conventional signs of dysplasia.

Journal: NPJ precision oncology
Published: May 06, 2025

Inflammatory stromal and T cells mediate human bone marrow niche remodeling in clonal hematopoiesis and myelodysplasia.

Inflammatory stromal and T cells mediate human bone marrow niche remodeling in clonal hematopoiesis and myelodysplasia.

Journal: Nature communications
Published: December 19, 2024

Inflammatory Mesenchymal Stromal Cells and IFN-responsive T cells are key mediators of human bone marrow niche remodeling in CHIP and MDS.

Inflammatory Mesenchymal Stromal Cells and IFN-responsive T cells are key mediators of human bone marrow niche remodeling in CHIP and MDS.

Journal: bioRxiv : the preprint server for biology
Published: December 09, 2024

Prognostic value of flow cytometry in myelodysplastic neoplasms (MDS): Composition of a FCM-prognostic score (FCM-PS) for overall survival.

Prognostic value of flow cytometry in myelodysplastic neoplasms (MDS): Composition of a FCM-prognostic score (FCM-PS) for overall survival.

Journal: HemaSphere
Published: December 01, 2024

Synthetic bone marrow images augment real samples in developing acute myeloid leukemia microscopy classification models.

Synthetic bone marrow images augment real samples in developing acute myeloid leukemia microscopy classification models.

Journal: NPJ digital medicine
Published: October 29, 2024

Age-stratified machine learning identifies divergent prognostic significance of molecular alterations in AML.

Age-stratified machine learning identifies divergent prognostic significance of molecular alterations in AML.

Journal: HemaSphere
Published: October 23, 2024

Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study).

Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study).

Journal: Blood
Published: March 12, 2024

Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium.

Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium.

Journal: HemaSphere
Published: January 31, 2024

Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms.

Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms.

Journal: Leukemia
Published: November 29, 2023

Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche.

Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche.

Journal: Leukemia
Published: November 16, 2023
Showing 1-12 of 23

Last Updated: 09/26/2026